1. Home
  2. EXP vs CORT Comparison

EXP vs CORT Comparison

Compare EXP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

HOLD

Current Price

$205.84

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$119.81

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXP
CORT
Founded
1963
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
9.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
EXP
CORT
Price
$205.84
$119.81
Analyst Decision
Hold
Buy
Analyst Count
9
5
Target Price
$227.11
$96.50
AVG Volume (30 Days)
445.6K
1.1M
Earning Date
05-19-2026
04-30-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
3.29
0.09
Revenue
$495,023,000.00
$761,407,000.00
Revenue This Year
$1.97
$26.08
Revenue Next Year
$1.95
$26.98
P/E Ratio
$60.93
$1,312.22
Revenue Growth
N/A
12.79
52 Week Low
$171.99
$28.66
52 Week High
$245.53
$122.21

Technical Indicators

Market Signals
Indicator
EXP
CORT
Relative Strength Index (RSI) 45.91 69.55
Support Level $202.15 $76.41
Resistance Level $223.21 $122.21
Average True Range (ATR) 6.32 3.87
MACD -0.86 0.22
Stochastic Oscillator 29.58 93.91

Price Performance

Historical Comparison
EXP
CORT

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: